TrialSignal transduction and targeted therapy2024

Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or metastatic pancreatic ductal adenocarcinoma following prior gemcitabine-based therapy (PAN-HEROIC-1): a phase 3 trial.

Jiujie Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.